Brief: Sutro Biopharma says restructuring costs estimated at $4.1 million to $4.3 million - SEC filing
29/09/2025 23:31
Sept 29 (Reuters) - Sutro Biopharma Inc STRO.O: SUTRO BIOPHARMA INC - RESTRUCTURING COSTS ESTIMATED AT $4.1 MILLION TO $4.3 MILLION - SEC FILING Source text: [ID:n0001193125-25-223434] Further company coverage: STRO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sutro Biopharma
See all newsBrief: Sutro Biopharma Announces First Patient Dosed In Phase 1 Trial Of STRO-006
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Sutro Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary
Sutro Biopharma tumbles after missing estimates